trial · primary record
Cemiplimab
Nasopharyngeal Carcinoma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2030-07 |
| Primary endpoint | Complete response rate |
| Registry ID | NCT07650266 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:52.238Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07650266
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cemiplimab · compound